INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 34 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,089,303 | +4.2% | 3,283,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,964,549 | -3.2% | 3,283,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,061,398 | -3.7% | 3,283,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,178,000 | +4.1% | 3,283,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,052,000 | -6.8% | 3,283,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,276,000 | -2.8% | 3,283,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,371,000 | -10.1% | 3,283,000 | -9.4% | 0.00% | 0.0% |
| Q3 2021 | $3,750,000 | -1.0% | 3,625,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,786,000 | -48.7% | 3,625,000 | -45.3% | 0.00% | -50.0% |
| Q1 2021 | $7,374,000 | -0.8% | 6,625,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $7,435,000 | +3.4% | 6,625,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $7,190,000 | +11.7% | 6,625,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,439,000 | +16.4% | 6,625,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,532,000 | -13.3% | 6,625,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,382,000 | +15.6% | 6,625,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $5,522,000 | -14.2% | 6,625,000 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $6,434,000 | +16.4% | 6,625,000 | +21.0% | 0.00% | 0.0% |
| Q1 2019 | $5,529,000 | +39.4% | 5,475,000 | +26.7% | 0.00% | +100.0% |
| Q2 2018 | $3,966,000 | +12.8% | 4,320,000 | +8.0% | 0.00% | 0.0% |
| Q1 2018 | $3,517,000 | – | 4,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |